Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.01% | 90.69 | 1.3% | $838.74m | |
| AMGN | Amgen Inc. | 0.89% | 188.34 | 1.2% | $621.82m | |
| GILD | Gilead Sciences, Inc. | 1.84% | 67.59 | 0.9% | $512.40m | |
| BIIB | Biogen Inc. | 2.51% | 332.87 | 1.3% | $445.54m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.17% | 423.97 | 2.6% | $305.14m | |
| ILMN | Illumina, Inc. | 2.51% | 299.82 | 3.5% | $302.67m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.27% | 188.07 | 1.9% | $269.75m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.77% | 129.42 | 2.0% | $233.68m | |
| LOXO | Loxo Oncology Inc | -0.03% | 234.66 | 12.7% | $170.39m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.65% | 138.45 | 15.4% | $148.57m | |
| A | Agilent Technologies, Inc. | 1.64% | 78.28 | 1.6% | $133.87m | |
| INCY | Incyte Corporation | 0.88% | 84.15 | 2.5% | $132.72m | |
| EXAS | Exact Sciences Corporation | 0.49% | 88.55 | 25.3% | $128.36m | |
| ARRY | Array BioPharma Inc. | 4.95% | 23.13 | 8.2% | $105.79m | |
| EXEL | Exelixis, Inc. | -0.18% | 22.26 | 6.4% | $97.74m |
Company Profile
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.